Idiopathic Hypersomnia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
DUBLIN, Nov. 29, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 3 clinical trial evaluating the efficacy and safety of JZP-258 for the treatment of idiopathic... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 3, 2018 Category: Pharmaceuticals Source Type: clinical trials

Sodium Oxybate in Idiopathic Hypersomnia
Condition: Idiopathic Hypersomnia Interventions: Drug: Sodium Oxybate Oral Solution 500 MG/ML; Drug: Placebos Sponsor: University Hospital, Montpellier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2018 Category: Research Source Type: clinical trials